Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2022-01-01
2023-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates
NCT00653874
Implementation of a Transcutaneous Bilirubinometer
NCT01622699
Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants
NCT03195998
Transcutaneous Bilirubinometry and Phototherapy
NCT04246229
TCB Self-Monitoring in Healthy Term and Near-Term Neonates
NCT06645158
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Materials and Methods: Term and preterm newborns who needed phototherapy between postnatal days 0-28 were included in the study. Total serum bilirubin values and transcutaneous bilirubin measurements by MBJ20-2019 Transcutaneous Handheld Bilirubinometer (Beijing M\&B Electronic Instruments Co. Ltd. China, 2019) from the exposed area (on sternum) and an unexposed area (forehead, covered with a radioopaque patch) were obtained before starting phototherapy, after 24 hours of phototherapy, and at 8 hours after phototherapy. The results were analyzed statistically using intraclass correlation coefficients (ICC).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Serum
Total Serum bilirubin
covered or open skin
transcutaneous mesarument of covered or open skin area
covered skin
Covered Skin Transcutaneous Bilirubin
covered or open skin
transcutaneous mesarument of covered or open skin area
exposed skin
Exposed skin Transcutaneous Bilirubin
covered or open skin
transcutaneous mesarument of covered or open skin area
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
covered or open skin
transcutaneous mesarument of covered or open skin area
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Hour
28 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dilek Kahvecioğlu
Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dilek Kahvecioglu, Assoc.Prof.
Role: PRINCIPAL_INVESTIGATOR
Ankara Training and Research Hospital
Dilek Kahvecioglu, Assoc.Prof.
Role: STUDY_CHAIR
Ankara Training and Research Hospital
Dilek Kahvecioglu, Assoc.Prof.
Role: STUDY_DIRECTOR
Ankara Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Training and Research Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.